New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression.
about
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat gliomaConcurrent chemoradiotherapy followed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced nasopharyngeal carcinoma: a retrospective controlled study.Nasopharyngeal carcinoma: treatments and outcomes in the 20th century.Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapyAnalysis of EGFR signaling pathway in nasopharyngeal carcinoma cells by quantitative phosphoproteomicsCorrelation of metallothionein expression with apoptosis in nasopharyngeal carcinomaHER-2 targeted treatment of osteosarcoma: the challenges of developing targeted therapy and prognostic factors for rare malignancies.Nasopharyngeal carcinoma: alternative treatment options after disease progression.Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma: a meta-analysis.Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma.Transcriptome meta-analysis reveals dysregulated pathways in nasopharyngeal carcinoma.Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells.Pretreatment pathologic prognostic factors in head and neck squamous cell carcinoma.The microcirculation of choroidal and ciliary body melanomas.Effect of AKT inhibition on epithelial-mesenchymal transition and ZEB1-potentiated radiotherapy in nasopharyngeal carcinoma.ERBB3 as an independent prognostic marker for nasopharyngeal carcinoma.Epstein-Barr virus-encoded latent membrane protein 1 co-expresses with epidermal growth factor receptor in nasopharyngeal carcinoma.Prognostic role of Ebstein-Barr virus latent membrane protein-1 and interleukin-10 expression in patients with nasopharyngeal carcinoma.Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro.Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study.Prognostıc value of increased HER2 expression in cancers of pancreas and biliary tree.Prognostic value of c-erbB2 and other markers in patients treated with chemotherapy for recurrent head and neck cancer.Immunohistochemical study identifying prognostic biomolecular markers in nasopharyngeal carcinoma treated by radiotherapy.Expression of MASPIN and angiogenin in nasopharyngeal carcinoma: Novel preliminary clinico-pathological evidenceCancer of the Nasopharynx in Children and Young Adults in ScandinaviaMolecular pathology parameters in human nasopharyngeal carcinoma
P2860
Q28365043-175B700A-026D-4CDB-844A-38DCB5D76E66Q33763893-90734634-9FB5-4EAF-9559-D438DF5239C5Q34631533-BF39DF04-B969-4233-A7A3-729054399F62Q34743875-5B4DAE38-B9AE-4C8D-89F3-8BEEB2C5063BQ35122077-1AECF570-2D64-4ABC-AF85-3280B1C49C83Q36621333-9001015E-413D-4D59-AD7A-26D238DE93DFQ37650306-108F21FA-FA20-420C-9D49-4E400BC7159EQ37705415-66EF3CB6-CEF9-436B-B6E2-A7479C866AF2Q38133425-3E258000-04FF-4551-A968-35C1846EF888Q38458593-807FF648-75B6-4825-A878-B4F94EA3FE1EQ38905388-20357121-07B1-4A8F-BE4D-42F8FCF06C18Q39517299-6FF8D386-4A90-434D-9C8E-2080F6872E58Q39689222-11415124-5FE3-441B-82D8-CE8190A74347Q40875057-E4ABF0B2-BCC7-4DA2-AE13-6C158FF8B492Q41625937-8630CFBA-6157-466A-A6B6-F96B71973A4BQ42927132-AD6233DB-7FB9-4ED6-953C-34E6EBF36F0CQ44449930-749F5032-12F6-4CA7-9D84-700AB11A5DECQ44464526-7671B991-9B7E-48DF-9891-E34808191211Q45546964-EC2F92D4-CB05-43DB-BBCE-1973242189B1Q46613450-95EF32A4-B891-4AD7-BCB9-2234C83FE88AQ50434295-CD9BB077-E173-4333-AAB7-EE5317D6FB21Q51075580-577CAE9A-F59B-4D07-A120-785B06CB4F9AQ54040780-4D152260-AFAF-422C-9252-E19AA25A1A44Q54559186-237DFE52-DBF6-4F54-9531-6E67CA46CA06Q58185285-E1832013-445A-423C-8137-2AA78F616B03Q58271435-4048B195-E193-4904-8C26-8B2B7B6B4E6DQ58876777-F4F23674-EBC5-493B-8F8E-FBB0A6F9DCA0
P2860
New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
New prognostic factors in naso ...... enesis and C-erbB2 expression.
@en
type
label
New prognostic factors in naso ...... enesis and C-erbB2 expression.
@en
prefLabel
New prognostic factors in naso ...... enesis and C-erbB2 expression.
@en
P2093
P2860
P1433
P1476
New prognostic factors in naso ...... enesis and C-erbB2 expression.
@en
P2093
Roychowdhury DF
Tseng A Jr
Weinburg V
P2860
P304
P356
10.1002/(SICI)1097-0142(19960415)77:8<1419::AID-CNCR1>3.0.CO;2-7
P407
P577
1996-04-01T00:00:00Z